These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31563916)

  • 1. Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.
    Mihara M; Ogawa Y; Nagasaka M; Kobayashi N; Shimizu H; Shinozawa K; Fukutake K; Inoue M; Murakami M; Handa H
    Acta Haematol; 2020; 143(5):486-490. PubMed ID: 31563916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recurrence of acquired factor V inhibitor after four years of remission].
    Akashi N; Ogawa Y; Yanagisawa K; Osaki Y; Shimizu H; Ishizaki T; Inoue M; Murakami M; Souri M; Ichinose A; Handa H
    Rinsho Ketsueki; 2019; 60(1):46-50. PubMed ID: 30726824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
    Sakatoku K; Takakuwa T; Miura A; Araki T; Fujitani Y; Yamamura R
    Acta Haematol; 2020; 143(5):478-480. PubMed ID: 31522179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired factor V inhibitor: a nation-wide study of 38 patients.
    Goulenok T; Vasco C; Faille D; Ajzenberg N; De Raucourt E; Dupont A; Frere C; James C; Rabut E; Rugeri L; Schleinitz N; Sacré K; Papo T;
    Br J Haematol; 2021 Mar; 192(5):892-899. PubMed ID: 33471937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
    Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor V inhibitors: a systematic review.
    Franchini M; Lippi G
    J Thromb Thrombolysis; 2011 May; 31(4):449-57. PubMed ID: 21052780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
    Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
    Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe bleeding caused by an inhibitor to coagulation factor V: a case report.
    Smid WM; de Wolf JT; Nijland JH; Bom VJ; van der Meer J
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):133-7. PubMed ID: 8180333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.
    Ogawa H; Souri M; Kanouchi K; Osaki T; Ohkubo R; Kawanishi T; Wakai S; Morikane K; Ichinose A
    Int J Hematol; 2019 Feb; 109(2):214-220. PubMed ID: 30446942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired factor V inhibitor responsive to corticosteroids in a patient with double cancers.
    Endo H; Kawauchi K; Tomimatsu M; Iga D; Ogasawara T; Yasuyama M; Saito T; Otsuka K; Aiba M
    Intern Med; 2007; 46(9):621-5. PubMed ID: 17473502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
    Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
    Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
    [No Abstract]   [Full Text] [Related]  

  • 12. A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
    Hoffmann C; Amiral J; Rezig S; Kerspern H; Jantzem H; Robin S; Collins A; Mornet C; Mingant F; Pan Petesch B; Ianotto JC; Lippert E; Galinat H
    Eur J Haematol; 2019 Aug; 103(2):137-139. PubMed ID: 31102471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone.
    Khalafallah A; Grabek J; Hayes R; Mohamed M
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23921688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
    Nakata K; Ueda S; Matsunaga H; Mima F; Ueda H; Yoshioka A; Kaneko S; Maruo K; Morris S; Yonemoto S; Hayashi D; Fujii N; Narahara H; Inui Y; Kawata S
    Intern Med; 2018 Feb; 57(3):393-397. PubMed ID: 29093398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful management of acquired factor V deficiency developing shortly after induction of hemodialysis].
    Matsumoto A; Ogawa Y; Osaki T; Souri M; Yanagisawa K; Ishizaki T; Naito C; Ishikawa T; Miyazawa Y; Shimizu H; Inoue M; Hayakawa M; Murakami M; Ichinose A; Handa H
    Rinsho Ketsueki; 2020; 61(5):445-450. PubMed ID: 32507806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired factor V inhibitor].
    Yamada S; Asakura H
    Rinsho Ketsueki; 2020; 61(7):791-798. PubMed ID: 32759567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired inhibitor against coagulation factor V with severe hematuria].
    Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
    Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
    Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
    Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.
    Kadohira Y; Yamada S; Hayashi T; Morishita E; Asakura H; Ichinose A
    Int J Hematol; 2018 Aug; 108(2):145-150. PubMed ID: 29611057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmune coagulation factor V/5 deficiency during chronic disseminated intravascular coagulation].
    Ishimori N; Wakabayashi M; Sakurai K; Suda A; Souri M; Osaki T; Ichinose A
    Rinsho Ketsueki; 2023; 64(2):113-118. PubMed ID: 36990730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.